Canixin DHPPI/L- 50 Dose
⬇️ PLEASE READ SHIPPING INFORMATION BELOW. PLEASE CALL US IF YOU HAVE ANY QUERIES REGARDING THIS ON 01904 463001
Regular price£311.04
/
Tax included.
- Temperature Controlled Shipping £9.99, we only dispatch temperature-sensitive medicines Monday to Thursday after the prescription has been verified. We send in temperature-controlled chilled packing with Royal Mail Special Delivery pre-1pm service (someone must be in to receive)
- We do not take any responsibility for unusable product due to a missed delivery.
- Please contact us on 01904463001 if you need a specific delivery date or to send directly to your vet.
How do I buy Prescription Medicines?
Three Easy Steps
1. Ask your vet for a written prescription
2. On vetmedi.co.uk, type in the name of the medicine in the search box at the top left, then purchase the amount permitted on your prescription.
3. Send your prescription to us via one of the below methods
Email: hello@vetmedi.co.uk
Post: VetMediUK, North House Farm, Skipwith, Selby, YO8 5SQ
Please include your order number on the prescription.
Canixin DHPPI/L 50 Doses
L is used for active immunisation of dogs from 8 weeks of age to: Prevent mortality and clinical signs caused by canine distemper virus. Prevent mortality and clinical signs caused by canine adenovirus type 1. Prevent clinical signs and mortality and reduce excretion caused by canine parvovirus in challenge studies performed with a CPV-2b strain. Prevent clinical signs and reduce excretion caused by canine parvovirus in a challenge study performed with a CPV-2c strain. Reduce respiratory clinical signs and viral excretion caused by canine parainfluenza virus and canine adenovirus type 2. Prevent mortality and reduce infection, clinical signs, kidney colonisation, renal lesions and urine shedding of L. canicola. Reduce infection, clinical signs, kidney colonisation and urine shedding of L. icterohaemorrhagiae. Onset of immunity: The onset of immunity has been demonstrated from 3 weeks after the primary vaccination for CDV, CAV-2 and CPV, 4 weeks for CAV-1 and CPiV, 5 weeks for L. canicola and 2 weeks for L. icterohaemorrhagiae. Duration of immunity: After the primary vaccination course, the duration of immunity lasts for one year for all components. After the annual booster, the duration of immunity lasts for 3 years for CDV, CAV-1, CAV-2 and CPV. In the duration of immunity studies one year after the basic vaccination scheme there was no significant difference between vaccinated and control dogs in viral excretion for CPiV and CAV-2, in reduction of kidney colonisation for L. Canicola and L. icterohaemorrhagiae, nor in renal lesions and urine shedding for L. Canicola. For CAV-2, the duration of immunity after the annual booster was not established by challenge, and is based on the presence of CAV-2 antibodies 3 years after the booster vaccination.
L is used for active immunisation of dogs from 8 weeks of age to: Prevent mortality and clinical signs caused by canine distemper virus. Prevent mortality and clinical signs caused by canine adenovirus type 1. Prevent clinical signs and mortality and reduce excretion caused by canine parvovirus in challenge studies performed with a CPV-2b strain. Prevent clinical signs and reduce excretion caused by canine parvovirus in a challenge study performed with a CPV-2c strain. Reduce respiratory clinical signs and viral excretion caused by canine parainfluenza virus and canine adenovirus type 2. Prevent mortality and reduce infection, clinical signs, kidney colonisation, renal lesions and urine shedding of L. canicola. Reduce infection, clinical signs, kidney colonisation and urine shedding of L. icterohaemorrhagiae. Onset of immunity: The onset of immunity has been demonstrated from 3 weeks after the primary vaccination for CDV, CAV-2 and CPV, 4 weeks for CAV-1 and CPiV, 5 weeks for L. canicola and 2 weeks for L. icterohaemorrhagiae. Duration of immunity: After the primary vaccination course, the duration of immunity lasts for one year for all components. After the annual booster, the duration of immunity lasts for 3 years for CDV, CAV-1, CAV-2 and CPV. In the duration of immunity studies one year after the basic vaccination scheme there was no significant difference between vaccinated and control dogs in viral excretion for CPiV and CAV-2, in reduction of kidney colonisation for L. Canicola and L. icterohaemorrhagiae, nor in renal lesions and urine shedding for L. Canicola. For CAV-2, the duration of immunity after the annual booster was not established by challenge, and is based on the presence of CAV-2 antibodies 3 years after the booster vaccination.
This is a temperature Controlled Medicine.
